Stryker (SYK) Change in Account Payables (2009 - 2026)
Stryker (SYK) posted quarterly Change in Account Payables of $71.0 million for Q2 2026, up 77.5% year-over-year from $40.0 million in Q2 2025, and up 135.86% on a QoQ basis from -$198.0 million in Q1 2026.
Stryker (SYK) Change in Account Payables (2009 - 2026) Analysis & Trends
Stryker has reported Change in Account Payables for 18 years, with the latest figure at $71.0 million in Q2 2026.
- Change in Account Payables for Q2 2026 came in at $71.0 million, up 77.5% year-over-year; the trailing twelve-month figure through Jun 2026 was $236.0 million (up 84.38% YoY), and the FY2025 annual result was $94.0 million, down 51.04% from the prior year.
- Change in Account Payables grew to $71.0 million in Q2 2026, from -$198.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $395.0 million in Q4 2024 and troughed at -$309.0 million in Q1 2025.
- A 5-year average of $29.2 million and a median of $46.0 million in 2024 frame the typical range for Change in Account Payables.
- The widest annual swing landed in 2024, when Change in Account Payables slumped 358.93%; it then surged 3100.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $179.0 million in 2022, then advanced by 8.94% to $195.0 million in 2023, then soared by 102.56% to $395.0 million in 2024, then fell by 24.3% to $299.0 million in 2025, then sank by 76.25% to $71.0 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $71.0 million in Q2 2026, -$198.0 million in Q1 2026, and $299.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.00 Mn |
| Jun 30, 2026 | 71.00 Mn |
| Mar 31, 2026 | -198.00 Mn |
| Mar 31, 2026 | -198.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Mar 31, 2024 | -257.00 Mn |
| Mar 31, 2024 | -257.00 Mn |